Sildenafil ratiopharm

Country: Unjoni Ewropea

Lingwa: Ingliż

Sors: EMA (European Medicines Agency)

Ixtrih issa

Ingredjent attiv:

sildenafil

Disponibbli minn:

Ratiopharm GmbH

Kodiċi ATC:

G04BE03

INN (Isem Internazzjonali):

sildenafil

Grupp terapewtiku:

Urologicals

Żona terapewtika:

Erectile Dysfunction

Indikazzjonijiet terapewtiċi:

Treatment of men with erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. In order for sildenafil to be effective, sexual stimulation is required.

Sommarju tal-prodott:

Revision: 19

L-istatus ta 'awtorizzazzjoni:

Authorised

Data ta 'l-awtorizzazzjoni:

2009-12-23

Fuljett ta 'informazzjoni

                                29
B. PACKAGE LEAFLET
30
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
SILDENAFIL RATIOPHARM 25 MG FILM
-
COATED TABLETS
sildenafil
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Sildenafil ratiopharm is and what it is used for
2.
What you need to know before you take Sildenafil ratiopharm
3.
How to take Sildenafil ratiopharm
4.
Possible side effects
5.
How to store Sildenafil ratiopharm
6.
Contents of the pack and other information
1.
WHAT SILDENAFIL RATIOPHARM IS AND WHAT IT IS USED FOR
WHAT SILDENAFIL RATIOPHARM IS
Sildenafil ratiopharm contains the active substance sildenafil which
belongs to a group of medicines
called phosphodiesterase type 5 (PDE5) inhibitors. This medicine
allows an erection to last long
enough for you to satisfactorily complete sexual activity. It reduces
the action of the natural chemical
in your body, which makes erections go away. Sildenafil ratiopharm
will only work when you are
sexually stimulated.
WHAT SILDENAFIL RATIOPHARM IS USED FOR
Sildenafil ratiopharm is a treatment for adult men with erectile
dysfunction, sometimes known as
impotence. This is when a man cannot get or keep a hard, erect penis
suitable for sexual activity.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE SILDENAFIL RATIOPHARM
DO
NOT TAKE SILDENAFIL RATIOPHARM
-
if you are allergic to sildenafil or any of the other ingredients of
this medicine (listed in section
6).
-
if you are taking medicines that contain nitrates (e.g. glycerol
trinitrate) or nitric oxide donors
(e.g. amyl nitrite, also called “
                                
                                Aqra d-dokument sħiħ
                                
                            

Karatteristiċi tal-prodott

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE MEDICINAL PRODUCT
Sildenafil ratiopharm 25 mg film-coated tablets
Sildenafil ratiopharm 50 mg film-coated tablets
Sildenafil ratiopharm 100 mg film-coated tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Sildenafil ratiopharm 25 mg film-coated tablets
Each film-coated tablet contains sildenafil citrate equivalent to 25
mg of sildenafil.
Sildenafil ratiopharm 50 mg film-coated tablets
Each film-coated tablet contains sildenafil citrate equivalent to 50
mg of sildenafil.
Sildenafil ratiopharm 100 mg film-coated tablets
Each film-coated tablet contains sildenafil citrate equivalent to 100
mg of sildenafil.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Film-coated tablet
Sildenafil ratiopharm 25 mg film-coated tablets
White to off-white, oblong film-coated tablet with edge.
Sildenafil ratiopharm 50 mg film-coated tablets
White to off-white, oblong film-coated tablet with edge and score line
on one side. The tablet can be
divided into equal doses.
Sildenafil ratiopharm 100 mg film-coated tablets
White to off-white, oblong film-coated tablet with edge and score line
on one side. The tablet can be
divided into equal doses.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Sildenafil ratiopharm is indicated in adult men with erectile
dysfunction, which is the inability to
achieve or maintain a penile erection sufficient for satisfactory
sexual performance.
In order for sildenafil to be effective, sexual stimulation is
required.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
_Posology_
_Use in adults _
The recommended dose is 50 mg taken as needed approximately one hour
before sexual activity.
Based on efficacy and tolerability, the dose may be increased to 100
mg or decreased to 25 mg. The
maximum recommended dose is 100 mg. The maximum recommended dosing
frequency is once per
day. If sildenafil is taken with food, the onset of activity may be
delayed compared to the fasted state
(see section 5.2).
3
_Special populations _
_ _
Elderl
                                
                                Aqra d-dokument sħiħ
                                
                            

Dokumenti f'lingwi oħra

Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Bulgaru 24-06-2022
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Bulgaru 24-06-2022
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Spanjol 24-06-2022
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Spanjol 24-06-2022
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Ċek 24-06-2022
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Ċek 24-06-2022
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Daniż 24-06-2022
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Daniż 24-06-2022
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Ġermaniż 24-06-2022
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Ġermaniż 24-06-2022
Rapport ta 'Valutazzjoni Pubblika Rapport ta 'Valutazzjoni Pubblika Ġermaniż 23-07-2013
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Estonjan 24-06-2022
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Estonjan 24-06-2022
Rapport ta 'Valutazzjoni Pubblika Rapport ta 'Valutazzjoni Pubblika Estonjan 23-07-2013
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Grieg 24-06-2022
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Grieg 24-06-2022
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Franċiż 24-06-2022
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Franċiż 24-06-2022
Rapport ta 'Valutazzjoni Pubblika Rapport ta 'Valutazzjoni Pubblika Franċiż 23-07-2013
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Taljan 24-06-2022
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Taljan 24-06-2022
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Latvjan 24-06-2022
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Latvjan 24-06-2022
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Litwanjan 24-06-2022
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Litwanjan 24-06-2022
Rapport ta 'Valutazzjoni Pubblika Rapport ta 'Valutazzjoni Pubblika Litwanjan 23-07-2013
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Ungeriż 24-06-2022
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Ungeriż 24-06-2022
Rapport ta 'Valutazzjoni Pubblika Rapport ta 'Valutazzjoni Pubblika Ungeriż 23-07-2013
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Malti 24-06-2022
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Malti 24-06-2022
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Olandiż 24-06-2022
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Olandiż 24-06-2022
Rapport ta 'Valutazzjoni Pubblika Rapport ta 'Valutazzjoni Pubblika Olandiż 23-07-2013
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Pollakk 24-06-2022
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Pollakk 24-06-2022
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Portugiż 24-06-2022
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Portugiż 24-06-2022
Rapport ta 'Valutazzjoni Pubblika Rapport ta 'Valutazzjoni Pubblika Portugiż 23-07-2013
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Rumen 24-06-2022
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Rumen 24-06-2022
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Slovakk 24-06-2022
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Slovakk 24-06-2022
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Sloven 24-06-2022
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Sloven 24-06-2022
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Finlandiż 24-06-2022
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Finlandiż 24-06-2022
Rapport ta 'Valutazzjoni Pubblika Rapport ta 'Valutazzjoni Pubblika Finlandiż 23-07-2013
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Svediż 24-06-2022
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Svediż 24-06-2022
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Norveġiż 24-06-2022
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Norveġiż 24-06-2022
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Iżlandiż 24-06-2022
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Iżlandiż 24-06-2022
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Kroat 24-06-2022
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Kroat 24-06-2022

Fittex twissijiet relatati ma 'dan il-prodott